Radiopharm Theranostics Limited (AU:RAD) has released an update.
Regal Funds Management Pty Ltd has emerged as a substantial holder in Radiopharm Theranostics Limited, controlling a 7.12% interest with 75,246,901 ordinary shares as of July 1, 2024. This move positions Regal Funds Management and its associates as significant players in the company’s future, reflecting a strategic investment step in the biotechnology and pharmaceutical sector.
For further insights into AU:RAD stock, check out TipRanks’ Stock Analysis page.
